GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain cancer: immune booster and drug combo tested
Disease control Not yet recruitingThis study tests two drugs—retifanlimab (an immunotherapy that helps the immune system attack cancer) and DFMO (which slows tumor growth)—in people with progressive high-grade gliomas, aggressive brain tumors. The goal is to find the safest and most effective dose and see if the …
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New radiation rhythm may boost brain cancer survival and save memory
Disease control Not yet recruitingThis study tests a new way of giving radiation therapy, called TMPRT, for people with a fast-growing brain cancer (glioblastoma) that is unlikely to respond to standard chemo. About 398 adults will get either standard radiation or TMPRT, both with the chemo drug temozolomide. The…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 04, 2026 16:24 UTC